Affymetrix CytoScan Dx Assay for postnatal detection of DNA CNVs
The Affymetrix CytoScan Dx Assay is intended for the postnatal detection of DNA copy number variants (CNV) in patients referred for chromosomal testing. It is designed to help physicians diagnose children’s developmental and intellectual disabilities more comprehensively by enabling a high-resolution genome-wide analysis of genetic aberrations.
The product analyses the whole genome in a single assay at very good resolution, improving diagnostic capability. High-resolution analysis can reveal small aberrations not readily seen using traditional techniques.
The company’s For Research Use Only version of the assay is currently available in Australia for both constitutional and cancer cytogenetics research applications.
Phone: 1800 678 242
Mercodia Insulin MBeads Assay
The assay is designed to offer high accuracy by specifically measuring human insulin while...
Waters BD FACSDiscover A7 Cell Analyzer
The BD FACSDiscover A7 Cell Analyzer combines high spectral resolution and sensitivity with...
Lumiprobe CytoTracer fluorescent cell dyes
The dyes rapidly penetrate cells, form intracellular membrane-impermeable products, and deliver...
